Epithelial–mesenchymal transition (EMT)-driven DDR2 upregulation maintains a growth advantage but results in ferroptosis susceptibility mediated by YAP/TAZ in recurrent tumors.168 Silencing DDR2 reduces the clonogenic proliferation of recurrent tumor cells. Here, DDR2 is linked to neoplasm.